These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34103942)

  • 1. Comparative Analysis and in vitro Experiments of Signatures and Prognostic Value of Immune Checkpoint Genes in Colorectal Cancer.
    Ma R; Qu X; Che X; Yang B; Li C; Hou K; Guo T; Xiao J; Liu Y
    Onco Targets Ther; 2021; 14():3517-3534. PubMed ID: 34103942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma.
    Li S; Dong C; Chen J; Gao X; Xie X; Zhang X
    Aging (Albany NY); 2021 Jun; 13(12):16696-16712. PubMed ID: 34158412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of immunologic subtype and prognosis of GBM based on TNFSF14 and immune checkpoint gene expression profiling.
    Long S; Li M; Liu J; Yang Y; Li G
    Aging (Albany NY); 2020 Apr; 12(8):7112-7128. PubMed ID: 32310827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer.
    Chen QY; Chen YX; Han QY; Zhang JG; Zhou WJ; Zhang X; Ye YH; Yan WH; Lin A
    Front Immunol; 2021; 12():679090. PubMed ID: 34054869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Checkpoint Gene Expression Profiling Identifies Programmed Cell Death Ligand-1 Centered Immunologic Subtypes of Oral and Squamous Cell Carcinoma With Favorable Survival.
    Yu Y; Tang H; Franceschi D; Mujagond P; Acharya A; Deng Y; Lethaus B; Savkovic V; Zimmerer R; Ziebolz D; Li S; Schmalz G
    Front Med (Lausanne); 2021; 8():759605. PubMed ID: 35127742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Novel Immunologic Checkpoint Gene Prognostic Markers for Ovarian Cancer.
    Huo X; Zhang X; Li S; Wang S; Sun H; Yang M
    J Oncol; 2022; 2022():8570882. PubMed ID: 36157232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an Immunologic Signature of Lung Adenocarcinomas Based on Genome-Wide Immune Expression Profiles.
    Ling B; Ye G; Zhao Q; Jiang Y; Liang L; Tang Q
    Front Mol Biosci; 2020; 7():603701. PubMed ID: 33505988
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel immune checkpoint-related gene signature for predicting overall survival and immune status in triple-negative breast cancer.
    Liu J; Ling Y; Su N; Li Y; Tian S; Hou B; Luo S; Zhao L; Shi M
    Transl Cancer Res; 2022 Jan; 11(1):181-192. PubMed ID: 35261895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
    Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S
    Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of immune subtypes and prognosis of hepatocellular carcinoma based on immune checkpoint gene expression profile.
    Xu D; Liu X; Wang Y; Zhou K; Wu J; Chen JC; Chen C; Chen L; Zheng J
    Biomed Pharmacother; 2020 Jun; 126():109903. PubMed ID: 32113055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune checkpoints expression patterns in early-stage triple-negative breast cancer predict prognosis and remodel the tumor immune microenvironment.
    Zhang J; Jin H; Pan S; Han C; Sun Q; Han X
    Front Immunol; 2023; 14():1073550. PubMed ID: 36814908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging glyco-risk prediction model to forecast response to immune checkpoint inhibitors in colorectal cancer.
    Qiu P; Chen X; Xiao C; Zhang M; Wang H; Wang C; Li D; Liu J; Chen Y; Liu L; Zhao Q
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6411-6434. PubMed ID: 36757621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response.
    Hu FF; Liu CJ; Liu LL; Zhang Q; Guo AY
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32814346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition.
    Fabrizio DA; George TJ; Dunne RF; Frampton G; Sun J; Gowen K; Kennedy M; Greenbowe J; Schrock AB; Hezel AF; Ross JS; Stephens PJ; Ali SM; Miller VA; Fakih M; Klempner SJ
    J Gastrointest Oncol; 2018 Aug; 9(4):610-617. PubMed ID: 30151257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel prognostic risk score model based on immune-related genes in patients with stage IV colorectal cancer.
    Xu K; He J; Zhang J; Liu T; Yang F; Ren T
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33034614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival.
    Sorrentino C; D'Antonio L; Fieni C; Ciummo SL; Di Carlo E
    Front Immunol; 2021; 12():778329. PubMed ID: 34975867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ERBB4 mutations in the prognosis of advanced non-small cell lung cancer treated with immune checkpoint inhibitors.
    Hu X; Xu H; Xue Q; Wen R; Jiao W; Tian K
    Mol Med; 2021 Oct; 27(1):126. PubMed ID: 34620079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
    Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
    BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of immune checkpoints is associated with the TIL load, mutation rate and patient survival in colorectal cancer.
    Kitsou M; Ayiomamitis GD; Zaravinos A
    Int J Oncol; 2020 Jul; 57(1):237-248. PubMed ID: 32468013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLAMF8, a potential new immune checkpoint molecule, is associated with the prognosis of colorectal cancer.
    Zhang Y; Zhang Q; Han X; Han L; Wang T; Hu J; Li L; Ding Z; Shi X; Qian X
    Transl Oncol; 2023 May; 31():101654. PubMed ID: 36931016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.